About Biogenero Labs Private Limited
Data last updated:
Biogenero Labs Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24233KA2009PTC051927. Its GSTIN is 29AADCB9324N1Z6 (Karnataka).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Malathi Bai and Savitha Velmurugan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Guru Krupa No 1368 2nd Main 2nd Cross Samrat Layout Arekere, Bangalore, Karnataka, India – 560076.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.77 Lakh, a decline of 97% compared to the previous year. For the same year it recorded a net loss of ₹5.88 Lakh (net margin -331.2%) and EBITDA of -₹5.8 Lakh (EBITDA margin -326.7%). Revenue has declined at a compounded annual rate (CAGR) of 87% over three years and 68% over five years.
The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹33 Lakh; the latest was in March 2020.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biogenero.in.
Company details
Contact details
Biogenero Labs Private Limited's registered office is in Bangalore, Karnataka. Its website is biogenero.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGuru Krupa No 1368 2nd Main 2nd Cross Samrat Layout Arekere, Bangalore, Karnataka, India – 560076
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biogenero Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biogenero Labs is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Biogenero Labs Private Limited, buy the company report.
Financials of Biogenero Labs Private Limited
FY 2024 filings availableBiogenero Labs Private Limited reported revenue of ₹1.77 Lakh (down 97% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 68% over five years, including a 97% fall in the latest year. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.8 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -326.7% | ||||
| Net Profit Margin | -331.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biogenero Labs Private Limited, buy the company report.
Board of directors of Biogenero Labs Private Limited
Biogenero Labs has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Malathi Bai | Director | 01 Dec 2011 | 14 Years 11 Months | Current |
| Savitha Velmurugan | Director | 30 Sep 2022 | 4 Years 1 Months | Current |
Auditor
Biogenero Labs Private Limited is audited by MAHESH V AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MAHESH V AND ASSOCIATES | FY 2023 | 011479S |
Shareholding
The shareholding of Biogenero Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biogenero Labs Private Limited, buy the company report.
Deals & funding
Biogenero Labs Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹33 Lakh; the latest was in March 2020.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2014 | Funding round | ₹20 Lakh | Investors: 2 individuals |
| Feb 2014 | Funding round | ₹13 Lakh | Investors: 2 individuals |
| Dec 2011 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Biogenero Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biogenero Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biogenero Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCB9324N1Z6 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biogenero Labs Private Limited, buy the company report.
Recent activity
Biogenero Labs Private Limited has 7 board changes on record since 2011: 2 appointments and 5 cessations. The latest: Suresh Narayan ceased to be Director on 12 Oct 2022.
Frequently asked questions
Biogenero Labs is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 December 2009 (17+ years old) and is registered under CIN U24233KA2009PTC051927.
Biogenero Labs has 2 current directors:
- Malathi Bai - Director
- Savitha Velmurugan - Director
The latest financial statements of Biogenero Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Biogenero Labs is 29AADCB9324N1Z6, registered in Karnataka.
The CIN (Corporate Identification Number) of Biogenero Labs is U24233KA2009PTC051927. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biogenero Labs was incorporated on 23 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Bangalore.
Biogenero Labs has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹33 Lakh; the latest was in March 2020.
Suresh Narayan ceased to be Director on 12 Oct 2022. Velmurugan Shanmugham ceased to be Managing Director on 12 Oct 2022. Savitha Velmurugan was appointed as Director on 30 Sep 2022. Biogenero Labs has 7 board changes on record in total.
Biogenero Labs can be reached through the website biogenero.in. Its registered office is in Bangalore, Karnataka, India.
The registered office of Biogenero Labs is at Guru Krupa No 1368 2nd Main 2nd Cross Samrat Layout Arekere, Bangalore, Karnataka, India – 560076.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
